Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000706988 | SCV000836064 | uncertain significance | MEGF10-related myopathy | 2020-10-14 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with glutamic acid at codon 505 of the MEGF10 protein (p.Gly505Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is present in population databases (rs199699950, ExAC 0.03%). This variant has not been reported in the literature in individuals with MEGF10-related conditions. ClinVar contains an entry for this variant (Variation ID: 582817). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |